Randomized clinical trial: a controlled pilot trial of the 5‐HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurogastroenterology and Motility

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/nmo.12736PMID 27010235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Placebo effects and their determinants in gastrointestinal disorders

  2015cited by this paper
• A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults

  2015cited by this paper
• Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment

  2014cited by this paper
• Phase 2b, randomized, double‐blind 12‐week studies of TZP‐102, a ghrelin receptor agonist for diabetic gastroparesis

  2013cited by this paper
• Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial.

  2013cited by this paper
• The Relation Between Symptom Improvement and Gastric Emptying in the Treatment of Diabetic and Idiopathic Gastroparesis

  2013cited by this paper
• Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

  2012cited by this paper
• Risk of Gastroparesis in Subjects With Type 1 and 2 Diabetes in the General Population

  2012cited by this paper
• Prevalence of Hidden Gastroparesis in the Community: The Gastroparesis "Iceberg"

  2012cited by this paper
• Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting

  2010cited by this paper
• Gastroparesis: Current Concepts and Management

  2009cited by this paper
• 5‐HT4 receptor agonists: similar but not the same

  2008cited by this paper
• Lower gastrointestinal functions

  2008cited by this paper
• Prokinetics and fundic relaxants in upper functional GI disorders.

  2008cited by this paper
• Clinical trial: a randomized‐controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis

  2007cited by this paper
• Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi‐center, placebo‐controlled trial

  2007cited by this paper
• Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis – a randomized, multicentre, placebo‐controlled study

  2007cited by this paper
• Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying

  2005cited by this paper
• American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis.

  2004cited by this paper
• Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders.

  2004cited by this paper
• Symptoms Associated With Impaired Gastric Emptying of Solids and Liquids in Functional Dyspepsia

  2003cited by this paper
• Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms

  2003cited by this paper
• Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index

  2003cited by this paper
• Access options for withdrawn motility-modifying agents

  2002cited by this paper
• Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

  2001cited by this paper
• Validation of a specific quality of life questionnaire for functional digestive disorders

  1999cited by this paper
• Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying

  1998cited by this paper
• Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

  1996cited by this paper
• The gastric proton pump, a target for neuroleptics and antidepressant drugs?

  1987cited by this paper
• Incidence , Prevalence , and Outcomes of Patients With Gastroparesis n Olmsted County , Minnesota , From 1996 to 2006

  year unknowncited by this paper

• Gastroparesis needs to be detected and treated

  2025cites this paper
• Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment

  2023cites this paper
• Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis

  2023cites this paper
• Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence

  2023cites this paper
• Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis.

  2022cites this paper
• The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy

  2022cites this paper
• Gastric peroral endoscopic myotomy in refractory gastroparesis: long-term outcomes and predictive score to improve patient selection.

  2022cites this paper
• Gastrointestinal hormones and regulation of gastric emptying

  2022cites this paper
• Response and Adverse Event Rates with Placebo in Gastroparesis: A Systematic Review and Meta-analysis.

  2022cites this paper
• ACG Clinical Guideline: Gastroparesis

  2022cites this paper
• Editorial: on the road towards treatment of gastroparesis—accelerating but do we get closer?

  2021cites this paper
• Evaluating response in gastroparesis: Patient reported outcome measures and survey instruments

  2021cites this paper
• One-year results of gastric peroral endoscopic myotomy for refractory gastroparesis: a French multicenter study

  2020cites this paper
• The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review

  2020cites this paper
• Association Between Symptoms, Quality of Life, and Gastric Emptying in Dyspeptic Patients

  2019cites this paper
• The Challenges of Gastroparesis: Changing Study Design to Improve Clinical Care

  2019cites this paper
• The American neurogastroenterology and motility society gastroparesis cardinal symptom index‐daily diary (ANMS GCSI‐DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis

  2019cites this paper
• Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.

  2019cites this paper
• Elevated Circulating Levels of Motilin are Associated with Diabetes in Individuals after Acute Pancreatitis.

  2019cites this paper
• Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders

  2019cites this paper
• Metoclopramide for the treatment of diabetic gastroparesis

  2019cites this paper
• Diabetic Gastroparesis and Glycaemic Control

  2019cites this paper
• Pharmacological Approaches to Diabetic Gastroparesis

  2019cites this paper
• Gastroparesis

  2019cites this paper
• Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function

  2018cites this paper
• Gastroparesis

  2018cites this paper
• The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis

  2018cites this paper
• The Investigation and Treatment of Diabetic Gastroparesis.

  2018cites this paper
• Gastrointestinal involvement in systemic sclerosis: diagnosis and management

  2018cites this paper
• Post-pancreatitis diabetes mellitus: towards understanding the role of gastrointestinal motility.

  2018cites this paper
• Investigational drug therapies for the treatment of gastroparesis

  2017cites this paper
• Prokinetics in the Management of Functional Gastrointestinal Disorders

  2017cites this paper
• Gastroparesis: Medical and Therapeutic Advances

  2017cites this paper
• Toward a Better Drug for Gastroparesis: The Problem With a Moving Target.

  2016cites this paper
• Chronic Unexplained Nausea and Vomiting or Gastric Neuromuscular Dysfunction (GND)? An Update on Nomenclature, Pathophysiology and Treatment, and Relationship to Gastroparesis

  2016cites this paper
• Prokinetics for functional dyspepsia.

  2011cites this paper